Profile data is unavailable for this security.
About the company
SymBio Pharmaceuticals Limited is a Japan-based pharmaceutical company. Along with medicine specialists, contract research organizations (CROs) and other pharmaceutical companies, the Company is engaged in the design and operation of clinical tests, the manufacture and sale of new drugs specializing in three therapeutic areas: cancer, blood diseases and autoimmune diseases. The Company develops new medicines using chemical compounds proofed by preclinical tests and clinical tests. The Company manufactures and sells medicines through domestic and foreign pharmaceutical companies. The Company's pipelines include anticancer drugs, such as SyB L-0501, SyB L-1101 and SyB C-1101.
- Revenue in JPY (TTM)4.64bn
- Net income in JPY-2.74bn
- Incorporated2005
- Employees109.00
- LocationSymBio Pharmaceuticals LtdToranomon 30 Mori Bldg.3-2-2, ToranomonMINATO-KU 105-0001JapanJPN
- Phone+81 354721125
- Fax+81 354723054
- Websitehttps://www.symbiopharma.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kidswell Bio Corp | 2.62bn | -1.21bn | 5.51bn | 41.00 | -- | 3.73 | -- | 2.11 | -37.72 | -37.72 | 77.56 | 37.57 | 0.5583 | 1.26 | 4.00 | 63,807,830.00 | -25.82 | -58.77 | -36.65 | -77.44 | 50.30 | 59.87 | -46.25 | -139.31 | 1.86 | -21.98 | 0.6118 | -- | 76.92 | 21.24 | -22.83 | -- | -- | -- |
| Cyfuse Biomedical KK | 61.11m | -589.21m | 5.69bn | 21.00 | -- | 1.77 | -- | 93.13 | -75.45 | -75.45 | 7.82 | 405.80 | 0.0135 | 0.5407 | 3.98 | 2,910,095.00 | -13.05 | -- | -15.34 | -- | 61.76 | -- | -964.15 | -- | 5.92 | -71.55 | 0.2218 | -- | -83.68 | -- | -24.32 | -- | -- | -- |
| Delta-Fly Pharma Inc | 0.00 | -1.26bn | 6.09bn | 11.00 | -- | 3.61 | -- | -- | -187.93 | -187.93 | 0.00 | 205.25 | 0.00 | -- | -- | 0.00 | -92.45 | -53.35 | -103.56 | -55.60 | -- | -- | -- | -769.75 | -- | -391.17 | 0.00 | -- | -100.00 | -- | -37.37 | -- | -- | -- |
| Noile-Immune Biotech Inc | 316.82m | -1.13bn | 6.71bn | 28.00 | -- | 1.18 | -- | 21.18 | -26.14 | -26.14 | 7.32 | 131.42 | 0.0608 | 0.1818 | -- | 11,314,930.00 | -21.69 | -- | -22.60 | -- | 99.29 | -- | -356.68 | -- | 66.04 | -- | 0.00 | -- | -49.37 | -- | -192.28 | -- | -- | -- |
| NIPPON CHEMIPHAR CO., LTD. | 30.61bn | -241.00m | 6.75bn | 872.00 | -- | 0.3048 | 5.65 | 0.2204 | -66.77 | -66.77 | 8,482.42 | 5,194.10 | 0.6063 | 2.09 | 2.65 | 35,106,650.00 | -0.4793 | 1.20 | -0.6777 | 1.74 | 25.09 | 34.53 | -0.7905 | 1.77 | 1.61 | -- | 0.4852 | 38.20 | -2.91 | -2.23 | -51.57 | -21.81 | -13.06 | -12.94 |
| Chiome Bioscience Inc | 682.46m | -1.22bn | 6.88bn | 51.00 | -- | 5.55 | -- | 10.08 | -24.67 | -24.67 | 13.77 | 22.00 | 0.3441 | 4.19 | 6.88 | 13,381,650.00 | -61.51 | -50.50 | -79.81 | -57.38 | 58.41 | 57.53 | -178.77 | -224.74 | 2.90 | -513.93 | 0.2009 | -- | 8.19 | 26.24 | 1.84 | -- | -- | -- |
| DNA Chip Research Inc | 490.46m | -248.29m | 7.15bn | 36.00 | -- | 9.75 | -- | 14.57 | -39.09 | -39.09 | 77.17 | 108.27 | 0.5292 | 9.84 | 3.11 | -- | -26.79 | -23.49 | -32.60 | -26.70 | 13.53 | 14.28 | -50.62 | -54.10 | 2.92 | -2,206.97 | -- | -- | 49.74 | 6.33 | 31.48 | -- | -15.75 | -- |
| K Pharma Inc | 1.00bn | 260.33m | 7.22bn | 15.00 | 27.39 | 2.32 | -- | 7.22 | 22.71 | 22.71 | 86.17 | 267.55 | -- | -- | -- | 66,666,670.00 | -- | -- | -- | -- | 91.00 | -- | 26.03 | -- | 18.48 | -- | 0.00 | -- | -- | -- | 166.34 | -- | -- | -- |
| CellSeed Inc | 190.13m | -846.53m | 7.28bn | 35.00 | -- | 3.28 | -- | 38.28 | -29.28 | -29.28 | 6.61 | 68.81 | 0.0948 | 1.62 | 4.90 | 5,432,400.00 | -42.22 | -49.69 | -45.69 | -54.55 | 56.36 | 63.66 | -445.23 | -428.62 | 18.66 | -601.01 | 0.0653 | -- | 50.39 | -28.62 | -11.43 | -- | 80.73 | -- |
| Symbio Pharmaceuticals Ltd | 4.64bn | -2.74bn | 7.57bn | 109.00 | -- | 1.06 | -- | 1.63 | -66.88 | -66.88 | 113.80 | 156.38 | 0.5439 | 2.76 | 5.14 | 42,594,130.00 | -32.15 | -19.18 | -35.33 | -23.62 | 78.38 | 65.84 | -59.12 | -24.32 | 10.43 | -- | 0.00 | -- | -44.15 | 7.82 | -266.45 | -- | 42.39 | -- |
| Carna Biosciences, Inc. | 1.63bn | -1.15bn | 7.67bn | 67.00 | -- | 1.98 | -- | 4.72 | -69.84 | -69.84 | 96.78 | 226.16 | 0.3774 | 1.36 | 3.35 | 24,267,000.00 | -26.76 | -14.45 | -29.55 | -16.95 | 89.22 | 90.59 | -70.91 | -35.42 | 10.78 | -312.97 | 0.0451 | -- | 17.24 | 16.59 | 14.57 | -- | -27.69 | -- |
| Veritas In Silico Inc | -100.00bn | -100.00bn | 7.75bn | 15.00 | -- | 3.28 | -- | -- | -- | -- | -- | 363.52 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 40.94 | -- | -- | -- | 101.54 | -- | 123.38 | -- | -- | -- |
| Kohjin Bio Co Ltd | -100.00bn | -100.00bn | 8.19bn | 157.00 | -- | 2.57 | -- | -- | -- | -- | -- | 634.95 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 1.15 | -- | 0.4102 | -- | 20.16 | -- | 41.20 | -- | -- | -- |
| Wakamoto Pharmaceutical Co Ltd | 7.98bn | -177.67m | 8.26bn | 292.00 | -- | 0.703 | 35.50 | 1.03 | -5.12 | -5.12 | 229.89 | 337.15 | 0.525 | 2.08 | 2.88 | 27,324,600.00 | -1.17 | -2.58 | -1.34 | -3.00 | 46.98 | 53.08 | -2.23 | -4.33 | 3.45 | -- | 0.0085 | -- | 3.31 | -4.50 | -42.04 | 1.88 | -17.49 | 0.00 |
| CanBas Co Ltd (Parent) | 0.00 | -1.09bn | 8.96bn | 12.00 | -- | 2.99 | -- | -- | -64.47 | -64.47 | 0.00 | 166.10 | 0.00 | -- | -- | 0.00 | -43.91 | -65.86 | -45.99 | -79.11 | -- | -- | -- | -1,094.10 | -- | -- | 0.00 | -- | -- | -- | -45.41 | -- | -- | -- |
| Tsubota Laboratory Inc | 246.60m | -1.07bn | 9.67bn | 10.00 | -- | 9.18 | -- | 39.21 | -42.31 | -42.31 | 9.94 | 41.17 | 0.1023 | 2.20 | 29.16 | 24,660,200.00 | -44.25 | -- | -64.34 | -- | -182.07 | -- | -432.63 | -- | 1.92 | -417.04 | 0.1046 | -- | 48.96 | -- | -41.18 | -- | -- | -- |
Data as of May 15 2024. Currency figures normalised to SymBio Pharmaceuticals Ltd's reporting currency: Japanese Yen JPY
0.62%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Simplex Asset Management Co., Ltd.as of 04 Apr 2024 | 181.90k | 0.41% |
| SSgA Funds Management, Inc.as of 04 Apr 2024 | 60.20k | 0.13% |
| Dimensional Fund Advisors LPas of 04 Apr 2024 | 34.20k | 0.08% |
| DFA Australia Ltd.as of 31 May 2023 | 2.27k | 0.01% |
| American Century Investment Management, Inc.as of 31 Jul 2023 | 1.00k | 0.00% |
| Dimensional Fund Advisors Ltd.as of 04 Apr 2024 | 600.00 | 0.00% |
More ▼
Data from 31 Dec 2023 - 09 May 2024Source: FactSet Research Systems Inc.
